Nadin Melina Conto-Palomino

Nadin Melina Conto-Palomino

Auto-generated profile, based on publicly available information

Nadin Melina Conto-Palomino

Facultad de Medicina Humana, Universidad Nacional Mayor de San Marcos, Lima, Perú. Servicio de pediatría, Hospital Nacional Arzobispo Loayza, Lima, Perú

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 August 2020 in Medwave
Verified
Journal Article
Open access
NCNadin Melina Conto-Palomino
Nadin Melina Conto-Palomino
MCMaría Luz Cabrera-Bueno
María Luz Cabrera-Bueno
KVKenneth Grenis Vargas-Ponce
Kenneth Grenis Vargas-Ponce
EREvelina Andrea Rondón-Abuhadba
Evelina Andrea Rondón-Abuhadba
NANoé Atamari-Anahui
Noé Atamari-Anahui
There are limited reports of neurological symptoms in the pediatric population with COVID-19. We report a 13-year-old girl with three days of illness characterized by headache, non-explosive vomiting, fever, and sudden-onset sensory disorder associated with difficulty in standing and hemiparesis in limbs without evidence of meningeal signs. Brain tomography revealed diffuse brain edema, and the cerebrospinal fluid study was consistent with a viral infection. COVID-19 was diagnosed based on serology. The patient had an untoward clinical course despite treatment with hydroxychloroquine, azithromycin, and corticosteroids, dying on the third day of hospitalization. Encephalitis in a patient with COVID-19 is not frequently reported in the pediatric population. It should be considered in the differential diagnosis in patients who arrives at the emergency with a sensory disorder or neurological symptomatology in the context of the COVID-19 pandemic.

21 August 2020 in Revista Peruana de Medicina Experimental Y Salud Pública
Verified
Journal Article
Open access
PDF file
NANoé Atamari-Anahui
Noé Atamari-Anahui
NCNadin Melina Conto-Palomino
Nadin Melina Conto-Palomino
CPCésar Johan Pereira-Victorio
César Johan Pereira-Victorio
Actividades de inmunización en el contexto de la pandemia por la COVID-19 en Latinoamérica

26 June 2023 in Revista Peruana de Medicina Experimental Y Salud Pública
Verified
Journal Article
Open access
PDF file
LCLisbeth Varenia Carrasco-Oros
Lisbeth Varenia Carrasco-Oros
NANoé Atamari-Anahui
Noé Atamari-Anahui
AGAlcida Goñi-Fano
Alcida Goñi-Fano
CSClaudia Sosa-Carmelo
Claudia Sosa-Carmelo
EGEduardo Jesús Guzmán-Quispe
Eduardo Jesús Guzmán-Quispe
CACarla Lisette Apeña-Cabrera
Carla Lisette Apeña-Cabrera
This study aimed to describe the clinical-epidemiological, laboratory, treatment, and follow-up characteristics of patients with hemolytic uremic syndrome (HUS). The medical records of patients with HUS hospitalized at the Instituto Nacional de Salud del Niño-Breña (INSN-B) (Lima, Peru) were reviewed. We evaluated 83 patients. The median age was 22 months (interquartile range: 14 to 30 months). Of the sample, 71.1% (59) registered previous use of antibiotics. Seventy-two (86.8%) had oligoanuria and 62 (74.6%) had diarrhea. Five cultures were positive (two enterohaemorrhagic Escherichia coli). Forty-nine (59%) required renal replacement therapy. No patient died during hospitalization. At one year of follow-up, seven patients developed post-HUS nephropathy. In conclusion, in INSN-B, the median age was like previous years and there was a higher frequency of oligoanuria, and renal replacement therapy compared to previous reports.